Status:
COMPLETED
The TARGET-EFT Randomized Clinical Trial
Lead Sponsor:
Jonathan Afilalo
Conditions:
Frailty
Cardiovascular Diseases in Old Age
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Randomized clinical trial to determine whether a multicomponent intervention will lead to improvements in mobility, self-care, mood, pain, and physical activity among frail and pre-frail older adults ...
Detailed Description
The investigators will conduct a single-center randomized clinical trial at the Jewish General Hospital; an academic tertiary care center in Montreal, Quebec. Researchers will pre-screen stable patien...
Eligibility Criteria
Inclusion
- Age ≥65 years
- Frail or pre-frail as defined by EFT score ≥1
- Admission to the JGH cardiovascular unit
- Signed informed consent
Exclusion
- Expected discharge within \<3 days
- Clinically unstable (unstable vital signs, low-threshold coronary ischemia, uncontrolled heart failure, uncontrolled arrhythmia)
- Awaiting cardiac surgery during the index hospitalization
- Severe dementia (MMSE ≤10/30)
- Delirium (CAM positive)
- Psychiatric condition precluding cooperation
- Not English or French speaking
- Parkinson's disease
- Recent stroke \<7 days
- Bed-bound or paraplegic
- End-of-life care plan
Key Trial Info
Start Date :
March 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04291690
Start Date
March 5 2020
End Date
September 24 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2